Innovate UK, part of UK Research and Innovation, will invest up to £15m in innovation projects by UK SMEs.

The aim of this industry-led R&D competition is to support SMEs to develop innovative solutions to address health, and healthcare, challenges.

Your project can focus on:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures
  • transforming the delivery of healthcare
  • the development of digital health technologies
  • consumer focused self-care

The industry led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. You must be able to demonstrate existing evidence of commercial and technical feasibility.

Your proposal must show how your project will improve the competitiveness and productivity of at least one UK SME partner involved in the project.

In applying to this competition, you are entering into a competitive process. This competition has a funding limit, so we may not be able to fund all the proposed projects. It may be the case that your project scores highly but we are still unable to fund it.

The competition closes Wednesday 16 October 2024 at 11am. Click here for more information.

 

Latest Opportunities

Funding opportunity: Biomedical Catalyst 2024 Round 1

Innovate UK, part of UK Research and Innovation, will invest up to £15m in innovation…

Blue Zone Consortium offers new funding opportunities for its members

The 2024 Blue Zone Consortium Flexible Talent Mobility Award (FTMA) funding call is now open. …

Opportunity for companies to provide database study for University of Leicester’s Diabetes Centre

The University of Leicester’s Diabetes Centre are working with a medical device company who have…

Latest News

Cellular Origins and 3P innovation collaborate to accelerate industrialisation of CGT manufacturing

Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell…

Shakespeare Martineau expands healthcare expertise with six-member team

As part of its growth strategy, full-service law firm Shakespeare Martineau has significantly bolstered its…

Gallagher releases new guide for leadership teams in the life sciences sector

Gallagher’s Directors & Officers’ (D&O) Insurance Guide provides crucial insights to help safeguard leadership teams…